Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker.
Related Posts
Bitcoin sets another record, crypto stocks soar as post-election rally continues: CNBC Crypto World
CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead […]
‘U.S. exceptionalism’ in stocks is taking a hit so look elsewhere for strong returns, BofA says
The Wall Street bank isn’t alone in warning that the period of phenomenal returns in U.S. markets may be faltering.
Europe and Iran to hold talks as Trump sets two-week deadline for U.S. strikes decision
European officials are hoping for a last-minute diplomatic breakthrough with Tehran to deter further escalations of the Middle East conflict.